New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 6, 2013
08:40 EDTROSGRosetta Genomics reports first payment from UK NHS for Cancer Origin Test
Rosetta Genomics announces that the National Health Service, or NHS, of the United Kingdom, has made its first payment to the company for use of the Rosetta Cancer Origin Test on a British citizen. The accurate identification of the primary tumor type in primary and metastatic cancer including cancer of unknown or uncertain primary is important in guiding clinician treatment decisions to maximize patient outcomes.
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 14, 2015
08:50 EDTROSGRosetta Genomics launches two assays for bladder cancer
Subscribe for More Information
May 13, 2015
09:09 EDTROSGRosetta Genomics receives U.S. Notice of Allowance for cancer test patent
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use